Emindole SB
Emindole SB is an anticancer agent. Emindole SB can be isolated from Penicillium species. Emindole SB exerts anticancer effects against ovarian cancer, breast cancer and lymphoma. Emindole SB shows no toxicity to Caenorhabditis elegans. Emindole SB can be used in studies related to ovarian cancer, lymphoma and breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 112900-04-6
- 分子式: C28H39NO
- 分子量:405.63
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Endogenous Metabolite アイソフォーム固有の製品をすべて表示
More
生物活性
|
Fungal Metabolite |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
8.2 μM
Compound: 10
|
Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 31117519] |
Emindole SB (at increasing concentrations; 72 h) inhibits the viability of mouse lymphoma L5178Y cells, with an IC50 of 18.3 μM[1].
Emindole SB (at increasing concentrations; 72 h) inhibits the viability of ovarian cancer A2780 cells, with an IC50 of 8.2 μM and a selectivity index of 5.4 relative to embryonic kidney HEK-293 cells[1].
Emindole SB (at increasing concentrations; 72 h) inhibits the viability of embryonic kidney HEK-293 cells with an IC50 of 44.6 μM[1].
Emindole SB (increasing concentrations; 72 h) exhibits no cytotoxic activity against bladder urothelial carcinoma cell line J82[1].
Emindole SB (72 h) inhibits the proliferation of breast cancer MCF-7 and MDA-MB-231 cells, with an IC50 of 10.1 μM for the former and 21.3 μM for the latter[2].
Emindole SB (multiple treatments; 24 h) inhibits the migration of breast cancer MDA-MB-231 cells, with an IC50 value of 19.0 μM[2].
Emindole SB (7.5-15.0 μM; 24 h) does not inhibit the invasion of breast cancer MDA-MB-231 cells at concentrations of 7.5 μM or 15.0 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:murine lymphoma L5178Y cells
-
Concentration:increasing concentrations
-
Incubation Time:72 h
-
Result:Exhibited cytotoxic activity against L5178Y cells with an IC50 value of 18.3 μM.
-
Cell Line:human ovarian cancer A2780 cells
-
Concentration:increasing concentrations
-
Incubation Time:72 h
-
Result:Exhibited pronounced cytotoxic activity against A2780 cells with an IC50 value of 8.2 μM.
Demonstrated a selectivity index (SI) of 5.4 calculated as the IC50 against HEK-293 cells divided by the IC50 against A2780 cells.
-
Cell Line:human embryonic kidney HEK-293 cells
-
Concentration:increasing concentrations
-
Incubation Time:72 h
-
Result:Exhibited cytotoxic activity against HEK-293 cells with an IC50 value of 44.6 μM.
-
Cell Line:human breast cancer MCF-7, MDA-MB-231 cell lines
-
Concentration:Multiple doses
-
Incubation Time:72 h
-
Result:Inhibited proliferation of MCF-7 cells with an IC50 of 10.1 μM.
Inhibited proliferation of MDA-MB-231 cells with an IC50 of 21.3 μM.
-
Cell Line:human breast cancer MDA-MB-231 cell line
-
Concentration:Multiple doses
-
Incubation Time:24 h
-
Result:Inhibited migration of MDA-MB-231 cells with an IC50 of 19.0 μM.
Emindole SB (10-50 μM; plate-incorporated; continuous exposure from L1 stage onward) shows no detectable toxicity to Caenorhabditis elegans at exposure concentrations up to 50 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:wild-type N2 Bristol strain (synchronized L1 stage larvae, incubated to L4 larval stage)[2]
-
Dosage:1.0 μM
-
Administration:plate-incorporated; continuous exposure from L1 to L4 larval stage
-
Result:Exhibited reversal counts comparable to vehicle (DMSO) control, with no statistically significant increase relative to control.
-
Animal Model:wild-type N2 Bristol strain (synchronized L1 stage larvae, observed over 7 days post-exposure)[2]
-
Dosage:10 μM; 50 μM
-
Administration:plate-incorporated; continuous exposure from L1 stage onward
-
Result:Showed no generalized effects on nematode viability or reproduction at either concentration.
化学情報
-
CAS 番号 112900-04-6
-
分子量 405.63
-
分子式 C28H39NO
-
SMILES
C[C@]12C3=C(C[C@@]1(CC[C@@]4([C@]2(C)CC[C@H](O)[C@]4(CCC=C(C)C)C)[H])[H])C=5C(N3)=CC=CC5
-
Structure Classification
-
Initial Source
Aspergillus oryzae
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Ariantari NP, et al. Indole Diterpenoids from an Endophytic Penicillium sp. J Nat Prod. 2019;82(6):1412-1423. [Content Brief]
[2]. Sallam AA, et al. Bioguided discovery and pharmacophore modeling of the mycotoxic indole diterpene alkaloids penitrems as breast cancer proliferation, migration, and invasion inhibitors. Medchemcomm. 2013;4(10):10.1039/C3MD00198A. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Emindole SB 関連分類
HY-N19113 関連分類
Powered by Bioz
- Emindole SB
- 112900-04-6
- Endogenous Metabolite
- BK channel
- human embryonic kidney HEK-293 cells
- murine lymphoma L5178Y cells
- human urothelial bladder cancer J82 cells
- human ovarian cancer A2780 cells
- lymphoma
- breast cancer
- Caenorhabditis elegans
- ovarian cancer
- human breast cancer MCF-7 cells
- Inhibitor
- inhibitor
- inhibit